Natural Product: NPC187376

Natural Product IDNPC187376
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Trametenolic Acid
IUPAC Name (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid
Synonyms Trametenolic Acid
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL387689
PubChem CID 12309443
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey NBSBUIQBEPROBM-GIICLEHTSA-N
Standard InCHI InChI=1S/C30H48O3/c1-19(2)9-8-10-20(26(32)33)21-13-17-30(7)23-11-12-24-27(3,4)25(31)15-16-28(24,5)22(23)14-18-29(21,30)6/h9,20-21,24-25,31H,8,10-18H2,1-7H3,(H,32,33)/t20-,21-,24+,25+,28-,29-,30+/m1/s1
SMILES CC(=CCC[C@H]([C@H]1CC[C@@]2([C@]1(C)CCC1=C2CC[C@@H]2[C@]1(C)CC[C@@H](C2(C)C)O)C)C(=O)O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   456.36 Volume:   511.671
?
Van der Waals volume.
Dense:   0.892 LogP:   4.379
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.423
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.192
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   22.0
TPSA:   57.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.42 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.708 Fsp3:   0.833
MCE-18:   81.455
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.919 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.019
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.005
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.571 Promiscuous compounds:   0.192

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.268 MDCK Permeability:   -4.917
Pgp-inhibitor:   0.003 Pgp-substrate:   0.098
PAMPA:   0.999
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.214 30% Bioavailability (F30%):   0.009
50% Bioavailability (F50%):   0.885

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.49 MRP1:   0.992
Plasma Protein Binding (PPB):   91.127% Volume Distribution (VD):   -0.302
Fu: 5.977%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   0.952 BCRP inhibitor:   0.021
BSEP inhibitor:   0.651

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.23 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.023 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.075 CYP3A4-substrate:   0.785
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.006
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.407 Half-life (T1/2):  0.558

ADMET: Toxicity

hERG Blockers:  0.011 hERG Blockers (10um):  0.055
Human Hepatotoxicity (H-HT):  0.598 Drug-induced Liver Injury (DILI):  0.212
AMES Toxicity:  0.206 Rat Oral Acute Toxicity:  0.15
Maximum Recommended Daily Dose:  0.12 Skin Sensitization:  0.998
Carcinogencity:  0.721 Eye Corrosion:  0.487
Eye Irritation:  0.935 Respiratory Toxicity:  0.767
Drug-induced Neurotoxicity:  0.017 Ototoxicity:  0.572
Hematotoxicity:  0.576 Drug-induced Nephrotoxicity:  0.937
Genotoxicity:  0.042 RPMI-8226 Immunitoxicity:  0.05
A549 Cytotoxicity:  0.095 Hek293 Cytotoxicity:  0.068
BCF:   1.805
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.544
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.825
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.324
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2085 Ganoderma tsugae Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[10785428]
NPO2085 Ganoderma tsugae Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[10785428]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[11975480]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota sclerotia n.a. n.a. PMID[17049251]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota sclerotia n.a. n.a. PMID[18387711]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota epidermis of the sclerotia n.a. n.a. PMID[19746919]
NPO2085 Ganoderma tsugae Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[21939217]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[24359303]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[27808511]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[8984162]
NPO2085 Ganoderma tsugae Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[9584403]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2085 Ganoderma tsugae Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO13025 Senecio lanceus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO9732 Glochidion heyneanum Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11286 Helichrysum bilobum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO11286 Helichrysum bilobum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13025 Senecio lanceus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9732 Glochidion heyneanum Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2085 Ganoderma tsugae Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO23577 Wolfiporia cocos Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT526 Individual protein Alpha-glucosidase MAL62 Saccharomyces cerevisiae IC50 = 17090.0 nM DOI[10.1007/s00044-011-9741-y]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell line Raji Homo sapiens Activity = 70.0 % PMID[17049251]
NPT550 Cell line T-24 Homo sapiens ED50 = 4.4 ug ml-1 PMID[10785428]
NPT2428 Cell line HT-3 Homo sapiens ED50 = 3.5 ug ml-1 PMID[10785428]
NPT2245 Cell line SiHa Homo sapiens ED50 = 5.5 ug ml-1 PMID[10785428]
NPT2306 Cell line Ca-Ski Homo sapiens ED50 = 6.2 ug ml-1 PMID[10785428]
NPT137 Cell line L1210 Mus musculus IC50 = 62500.0 nM PMID[23092389]
NPT28438 Unchecked Unchecked n.a. IC50 = 102.3 nM PMID[37847948]
NPT28438 Unchecked Unchecked n.a. Activity = 75.0 % PMID[29353722]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 75.0 % PMID[24359303]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 9.2 % PMID[17049251]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 45.0 % PMID[17049251]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 75.4 % PMID[17049251]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition = 98.6 % PMID[17049251]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. Survival = 92.0 % PMID[24359303]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC187376 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC233836
1.0 High Similarity NPC159046
0.7833 Intermediate Similarity NPC55309
0.7833 Intermediate Similarity NPC28252
0.7705 Intermediate Similarity NPC469400
0.7581 Intermediate Similarity NPC76895
0.7581 Intermediate Similarity NPC173272
0.75 Intermediate Similarity NPC482518
0.6818 Remote Similarity NPC148414
0.6818 Remote Similarity NPC111585
0.6818 Remote Similarity NPC175628
0.6769 Remote Similarity NPC84271
0.6769 Remote Similarity NPC102414
0.6719 Remote Similarity NPC201912
0.6719 Remote Similarity NPC38350
0.6719 Remote Similarity NPC601139
0.6418 Remote Similarity NPC142361
0.6418 Remote Similarity NPC474684
0.629 Remote Similarity NPC46160
0.629 Remote Similarity NPC202642
0.6154 Remote Similarity NPC94755
0.6094 Remote Similarity NPC214570
0.6 Remote Similarity NPC469406
0.5882 Remote Similarity NPC482908
0.5882 Remote Similarity NPC48330
0.5882 Remote Similarity NPC484974
0.5882 Remote Similarity NPC23434
0.5781 Remote Similarity NPC275910
0.5714 Remote Similarity NPC289213
0.5634 Remote Similarity NPC484976
0.5634 Remote Similarity NPC77168
0.5556 Remote Similarity NPC475921
0.5556 Remote Similarity NPC474704
0.5352 Remote Similarity NPC222845
0.5352 Remote Similarity NPC296577
0.5278 Remote Similarity NPC474889
0.5231 Remote Similarity NPC606082
0.5224 Remote Similarity NPC231477
0.5224 Remote Similarity NPC87489
0.5224 Remote Similarity NPC123724
0.5211 Remote Similarity NPC486193
0.5152 Remote Similarity NPC118508
0.5152 Remote Similarity NPC484086
0.5147 Remote Similarity NPC132635
0.5147 Remote Similarity NPC601223
0.5072 Remote Similarity NPC471724

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC187376 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data